CEL-SCI Announces Results of Annual Shareholders’ Meeting and Adjournment of Meeting to July 25, 2013 with Respect to Proposal Concerning Stock Option Plan

Published: Jun 27, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CEL-SCI Corporation (NYSE MKT: CVM). The annual meeting of CEL-SCI’s shareholders was held on June 25, 2013. At the meeting, all nominees to the Board of Directors were elected and the following proposals were ratified by the shareholders.

(1) the adoption of CEL-SCI’s Amended and Restated Articles of Incorporation;

(2) subject to the determination of CEL-SCI’s directors that a reverse split would be in the best interest of CEL-SCI’s shareholders, the adoption of a reverse split of CEL-SCI’s common stock. A condition of the reverse stock split is that the ratio of the reverse split will be determined by CEL-SCI’s Board of Directors, provided that, in any case, the reverse split ratio will not be greater than 10 for 1. The Board of Directors may elect not to proceed with a stock split without further action by the shareholders;

Help employers find you! Check out all the jobs and post your resume.

Back to news